Patterns of Sensitivity Exhibited By Venetoclax-Inclusive Drug Combinations in Acute Myeloid Leukemia

被引：1
|
作者：
Kurtz, Stephen E. [1 ,2 ]
Eide, Christopher A. [1 ]
Kaempf, Andy [3 ]
Long, Nicola [1 ]
Agarwal, Anupriya [1 ]
Tognon, Cristina E. [1 ]
Mori, Motomi [3 ]
Druker, Brian J. [1 ]
Tyner, Jeffrey W. [4 ]
机构：
[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Mail Code KR HEM, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Knight Canc Inst, Mail Code KR HEM, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Biostat Shared Resource, Portland, OR 97201 USA
[4] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-126020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
878
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Prescription patterns of venetoclax in acute myeloid leukemia
    Ucciero, Andrealuna
    Traversa, Giuseppe
    Pisterna, Alessia
    Cardinali, Valeria
    Sciabolacci, Sofia
    Poloni, Antonella
    Capelli, Debora
    Gaidano, Gianluca
    Patriarca, Andrea
    Lunghi, Monia
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (04)
  • [2] Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia
    Qin, Guangrong
    Dai, Jin
    Chien, Sylvia
    Martins, Timothy J.
    Loera, Brenda
    Nguyen, Quy H.
    Oakes, Melanie L.
    Tercan, Bahar
    Aguilar, Boris
    Hagen, Lauren
    Mccune, Jeannine
    Gelinas, Richard
    Monnat, Raymond J.
    Shmulevich, Ilya
    Becker, Pamela S.
    CLINICAL CANCER RESEARCH, 2024, 30 (12) : 2659 - 2671
  • [3] Drug-drug interactions with venetoclax in acute myeloid leukemia
    Tubay, Saziye Esra
    Celik, Serhat
    Unal, Ali
    ISTANBUL JOURNAL OF PHARMACY, 2024, 54 (03): : 345 - 349
  • [4] Venetoclax in acute myeloid leukemia
    Bruzzese, Antonella
    Martino, Enrica Antonia
    Mendicino, Francesco
    Lucia, Eugenio
    Olivito, Virginia
    Neri, Antonino
    Morabito, Fortunato
    Vigna, Ernesto
    Gentile, Massimo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (04) : 271 - 276
  • [5] Venetoclax in Acute Myeloid Leukemia
    Mihaila, Romeo G.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2023, 18 (01) : 11 - 28
  • [6] Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia
    Kurtz, Stephen E.
    Eide, Christopher A.
    Kaempf, Andy
    Long, Nicola
    Bottomly, Daniel
    Nikolova, Olga
    Druker, Brian J.
    McWeeney, Shannon K.
    Chang, Bill H.
    Tyner, Jeffrey W.
    Agarwal, Anupriya
    BLOOD ADVANCES, 2022, 6 (10) : 3062 - 3067
  • [7] Utility of therapeutic drug monitoring of venetoclax in acute myeloid leukemia
    Masayuki Kobayashi
    Takeo Yasu
    Ken Suzaki
    Nobuharu Kosugi
    Medical Oncology, 39
  • [8] Utility of therapeutic drug monitoring of venetoclax in acute myeloid leukemia
    Kobayashi, Masayuki
    Yasu, Takeo
    Suzaki, Ken
    Kosugi, Nobuharu
    MEDICAL ONCOLOGY, 2022, 39 (12)
  • [9] Building on Foundations: Venetoclax-Based Combinations in the Treatment of Acute Myeloid Leukemia
    Oyogoa, Emmanuella
    Traer, Elie
    Tyner, Jeffrey
    Lachowiez, Curtis
    CANCERS, 2023, 15 (14)
  • [10] Venetoclax-based combinations for the treatment of newly diagnosed acute myeloid leukemia
    Othman, Tamer A.
    Azenkot, Tali
    Moskoff, Benjamin N.
    Tenold, Matthew E.
    Jonas, Brian A.
    FUTURE ONCOLOGY, 2021, 17 (23) : 2989 - 3005
12345